Novel preparation techniques for alginate-poloxamer microparticles controlling protein release on mucosal surfaces.
Abstract
The objective of this study was to develop novel preparation techniques for protein-loaded, controlled release alginate-poloxamer microparticles with a size range suitable for pulmonary administration. Bovine serum albumin (BSA)-loaded microparticles were prepared by spray-drying aqueous polymer-drug solutions, followed by cross-linking the particles in aqueous or ethanolic CaCl(2) or aqueous ZnSO(4) solutions. The microparticles were characterized with respect to their morphology (optical and scanning electron microscopy), particle size (laser light diffraction), calcium content (atom absorption spectroscopy), alginate content (complexation with 1,9-dimethyl methylene blue) and in vitro drug release (modified Franz diffusion cell). The spray-dried microparticles were spherical in shape with a size range of 4-6μm. Aqueous cross-linking led to a significant size increase (10-15μm), whereas ethanolic cross-linking did not. The substantial drug loss (∼50%) during aqueous CaCl(2) cross-linking could be avoided by using aqueous ZnSO(4) or ethanolic CaCl(2) solutions. Protein release from microparticles cross-linked with ethanolic CaCl(2) solutions was much faster than in the case of aqueous CaCl(2) solutions, probably due to the lower calcium content. The salt concentration and temperature of the cross-linking solutions also affected the composition of and drug release from the microparticles. Cross-linked alginate-poloxamer microparticles can be produced in a size range appropriate for deep lung delivery and with controlled protein release kinetics (time frame: hours to days) with these novel preparation techniques. The systems offer an interesting potential for the controlled mucosal delivery of protein drugs.
Links
Authors
Moebus K, Siepmann J, Bodmeier R
Institution
College of Pharmacy, Freie Universität Berlin, Kelchstrasse 31, 12169 Berlin, Germany.
Source
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 45:3 2012 Feb 14 pg 358-66MeSH
AlginatesAnimals
Calcium Chloride
Capsules
Cattle
Delayed-Action Preparations
Drug Carriers
Drug Compounding
Humans
Microscopy, Electron, Scanning
Mucous Membrane
Particle Size
Serum Albumin, Bovine
Solvents
Terbutaline
Zinc Sulfate
Pub Type(s)
Journal ArticleLanguage
eng
PubMed ID
22178531
Log In

